Position in INSM
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$245,443
-$15,791 QoQ
Shares Held
1,501
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Knollwood Investment Advisory, LLC holds $8,326,743 across 7 Biotechnology names. INSM ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABOS |
Acumen Pharmaceuticals, Inc.
|
1,628,510 | $3,843,283 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,988 | $2,227,341 | |
| 3 | ARGX |
Argenx SE
|
1,379 | $1,007,014 | |
| 4 | BNTX |
BioNTech SE
|
5,479 | $486,973 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
1,111 | $329,933 | |
| 6 | INSM |
INSMED Inc
This page
|
1,501 | $245,443 | |
| 7 | CAI |
Caris Life Sciences, Inc.
|
10,445 | $186,756 |
All Filings in INSM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $245,443 | 1,501 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $261,234 | 1,501 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $216,159 | 1,501 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||